NPI: 1801050604 · PHOENIX, AZ 85042 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/11/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/11/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,211 | $612K |
| 2019 | 25,875 | $891K |
| 2020 | 32,031 | $1.05M |
| 2021 | 29,007 | $936K |
| 2022 | 20,686 | $680K |
| 2023 | 10,845 | $543K |
| 2024 | 7,656 | $537K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 55,432 | 4,413 | $5.05M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 565 | 316 | $197K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,236 | 2,386 | $1K |
| 83970 | 591 | 517 | $8.82 | |
| 82728 | 607 | 532 | $3.06 | |
| 84466 | 1,111 | 975 | $2.78 | |
| J1756 | Injection, iron sucrose, 1 mg | 9,677 | 2,241 | $2.02 |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,648 | 1,840 | $1.60 |
| 83540 | 620 | 541 | $1.44 | |
| 85041 | 1,054 | 924 | $0.68 | |
| A4657 | Syringe, with or without needle, each | 16,689 | 2,713 | $0.12 |
| 85048 | 1,025 | 901 | $0.00 | |
| 82108 | 148 | 129 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 4,021 | 326 | $0.00 |
| 90662 | 59 | 54 | $0.00 | |
| 90661 | 17 | 17 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 2,034 | 167 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 381 | 339 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 199 | 188 | $0.00 |
| 90674 | 104 | 102 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 93 | 71 | $0.00 |